In 2020, Credo Biomedical debuted its rapid flu test in the international arena. This series looks at the challenges that fledgling ventures face if they choose to go global and why some companies take the leap. Follow the founders of each company as they navigate key goals and examine whether they succeed in meeting the real-time challenges of product development and sales that they set for themselves.
Credo Diagnostics Receives Excellence in Diagnostic Innovation at MedTech World Asia Awards 2026
A milestone in our mission to bring advanced molecular diagnostics closer to patients and veterinary care. Credo Diagnostics Biomedical received the Excellence in Diagnostic Innovation




